Huuhtanen, Jani http://orcid.org/0000-0003-2750-4033
Bhattacharya, Dipabarna
Lönnberg, Tapio http://orcid.org/0000-0003-4484-5657
Kankainen, Matti http://orcid.org/0000-0002-4714-9481
Kerr, Cassandra
Theodoropoulos, Jason
Rajala, Hanna http://orcid.org/0000-0003-2675-2385
Gurnari, Carmelo http://orcid.org/0000-0001-6829-5544
Kasanen, Tiina
Braun, Till
Teramo, Antonella http://orcid.org/0000-0002-2754-699X
Zambello, Renato http://orcid.org/0000-0002-8799-5324
Herling, Marco
Ishida, Fumihiro http://orcid.org/0000-0002-0525-7636
Kawakami, Toru http://orcid.org/0000-0003-0178-5332
Salmi, Marko
Loughran, Thomas
Maciejewski, Jaroslaw P. http://orcid.org/0000-0002-6837-4346
Lähdesmäki, Harri
Kelkka, Tiina http://orcid.org/0000-0003-1085-6382
Mustjoki, Satu http://orcid.org/0000-0002-0816-8241
Funding for this research was provided by:
Academy of Finland
Signe ja Ane Gyllenbergin Säätiö
Article History
Received: 14 June 2021
Accepted: 17 February 2022
First Online: 11 April 2022
Competing interests
: T.L. is a member of the scientific advisory boards and hold stock options of Keystone Nano, Dren Bio, and Kymera Therapeutics (not related to this project). S.M. has received honoraria and research funding from BMS and research funding from Novartis and Pfizer (not related to this project). The remaining authors declare no competing interests.